Analyst Ratings for Adaptimmune Therapeutics plc (ADAP)

ADAP Rating Summary

ADAP Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ADAP
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $0.50 (+900%) * Over Last 12-Mos
Rating Score: 4.6 / 10   Percentile Rank: 47%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/29/2025 H.C. Wainwright Arthur He Downgrade Neutral
(Buy)
N/A
(N/A)
0.10
(0.05)
-50% Details
6/25/2025 Mizuho Graig Suvannavejh Downgrade Neutral
(Outperform)
0.50
(1.50)
0.25
(0.05)
-80% Details